About Index Trending news
Analyze
Top 50 Pricing
RedHill Biopharma

RedHill Biopharma

Work at RedHill Biopharma? Add yourself to this profile

RedHill Biopharma

RedHill Biopharma (NASDAQ/TASE: RDHL) is a biopharmaceutical company focused on development of late-stage drugs for inflammatory and gastrointestinal diseases

Elsewhere

Alexa global traffic share

Twitter followers

22 Jan 2014
$11,700,000
Post-IPO equity
31 Dec 2013
$8,500,000
Post-IPO equity